• Publications
  • Influence
Systemic mastocytosis and bone involvement in a cohort of 75 patients
Objectives To investigate bone involvement in a large cohort of systemic mastocytosis (SM) patients, and evaluate the efficacy of bisphosphonate therapy. Patients and Methods From 2000 to 2004, 75Expand
  • 120
  • 10
Direct and indirect evidence for the reversibility of cirrhosis.
The aim of this study was to assess the reversibility of cirrhosis after therapy in a large series of patients with cirrhosis from various etiologies. We performed a retrospective study of 113Expand
  • 90
  • 3
Phenotypic and Genotypic Characteristics of Mastocytosis According to the Age of Onset
Adult's mastocytosis is usually associated with persistent systemic involvement and c-kit 816 mutation, while pediatrics disease is mostly limited to the skin and often resolves spontaneously. WeExpand
  • 148
  • 2
  • PDF
Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study.
OBJECTIVES To identify juvenile idiopathic arthritis (JIA) patients who developed IBD during treatment with anti-TNF-alpha agents and better characterize the IBD clinical and pathologicalExpand
  • 46
  • 2
Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial
A previous pilot study with rituximab, gemcitabine and oxaliplatin showed promising activity in patients with refractory/relapsed B-cell lymphoma. We, therefore, conducted a phase II study toExpand
  • 64
  • 1
  • PDF
Arsenic trioxyde in the treatment of HTLV1 associated ATLL
Background The prognosis of Adult T-cell leukemia/lymphoma (ATLL) associated with HTLV1 is dismal. The response to conventional chemotherapy ranges between 20 and 70% and relaspe is constant. MedianExpand
  • 12
  • 1
A familial T‐cell lymphoma with γδ phenotype and an original location: Possible role of chronic Epstein–Barr virus infection
We describe a familial lymphoproliferative syndrome associated with Epstein–Barr Virus (EBV) infection and the γδ phenotype.
  • 19
Fas ligand-mediated lethal hepatitis after rapid lysis of a localized natural killer cell lymphoma.
Natural killer (NK) cell malignancies have been associated with neutropenia and disturbances of liver function tests, thought to be related to high levels of soluble Fas ligand (FasL) in theExpand
  • 3
Rituximab Combined to ACVBP (R-ACVBP) Supported by Pegfilgrastim as a New Inductive Treatment Followed by High-Dose Consolidative Autotransplantation (HDC) for Poor Risk Diffuse Large B-Cell Lymphoma
ACVBP dose-intense induction regimen followed by HDC provides a better event-free survival and overall survival (OS) as compared to a conventional consolidative treatment in responding patients (pts)Expand
  • 1